High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study

• Published in: Clinical Infectious Diseases
• Main Authors: Johannesson, Jon M, Fridriksdottir, Ragnheidur H, Löve, Thorvardur J, Runarsdottir, Valgerdur, Hansdóttir, Ingunn, Löve, Arthur, Thordardottir, Marianna, Hernandez, Ubaldo B, Olafsson, Sigurdur, Gottfredsson, Magnus, Bjornsson, Einar Stefan, Bergmann, Ottar Mar, Sigurdardottir, Bryndis, Johannsson, Birgir, Heimisdottir, Maria, Tyrfingsson, Thorarinn, Tomasdottir, Anna, Karlsdottir, Bergthora, Ingibergsdottir, Bjartey, Fridjonsdottir, Hildigunnur, Alexiusdottir, Kristin, Bjornsdottir, Thora, Olafsdottir, Bryndis, Finnbogadottir, Asdis M
• Format: Article in Journal/Newspaper
• Language: English
• Published: Oxford University Press (OUP) 2022
• Subjects: Random Point; Iceland
• Online Access: http://dx.doi.org/10.1093/cid/ciac272; https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac272/43954255/ciac272.pdf; https://academic.oup.com/cid/article-pdf/75/10/1732/47029343/ciac272.pdf

Abstract Background The Treatment as Prevention for Hepatitis C program started in 2016 in Iceland, offering treatment with direct-acting antivirals to hepatitis C virus (HCV)-infected individuals. Reinfections through injection drug use (IDU) can hamper elimination efforts. We determined reinfectio...